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Abstract
Introduction: Acute infection with HIV in the postpartum period results in a high risk of vertical transmission through
breastfeeding. A study was done to determine the HIV incidence rate and associated risk factors among postpartum women in
Southern Mozambique, where HIV prevalence among pregnant women is 21%.
Methods: A prospective cohort study was conducted in six rural health facilities in Gaza and Maputo provinces from March 2008
to July 2011. A total of 1221 women who were HIV-negative on testing at delivery or within two months postpartum were
recruited and followed until 18 months postpartum. HIV testing, collection of dried blood spot samples and administration of
a structured questionnaire to women were performed every three months. Infant testing by DNA-PCR was done as soon as
possible after identification of a new infection in women. HIV incidence was estimated, and potential risk factors at baseline
were compared using Poisson regression.
Results: Data from 957 women were analyzed with follow-up after the enrolment visit, with a median follow-up of 18.2 months.
The HIV incidence in postpartum women is estimated at 3.20/100 women-years (95% CI: 2.304.46), with the highest rate
among 18- to 19-year-olds (4.92 per 100 women-years; 95% CI: 2.659.15). Of the new infections, 14 (34%) were identified
during the first six months postpartum, 11 (27%) between 6 and 12 months and 16 (39%) between 12 and 18 months
postpartum. Risk factors for incident HIV infection include young age, low number of children, higher education level of the
woman’s partner and having had sex with someone other than one’s partner. The vertical transmission was 21% (95% CI: 536)
among newly infected women.
Conclusions: Incidence of HIV is high among breastfeeding women in Southern Mozambique, contributing to increasing numbers
of HIV-infected infants. Comprehensive primary prevention strategies targeting women of reproductive age, particularly
pregnant and postpartum women and their partners, will be crucial for the elimination of paediatric AIDS in Africa.
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Introduction
In 2012, 2.3 million new HIV infections occurred worldwide
with 1.6 million of these in sub-Saharan Africa. Every day,
about 6300 adults are infected globally, of which 34% are
women aged 1524 years [1].
Maternal acquisition of HIV during the breastfeeding period
and subsequent risk of transmission to the infant places a
high burden on efforts to eliminate paediatric HIV infection
[2]. Infants born to mothers with acute HIV infection during
pregnancy or breastfeeding have approximately double the
risk of acquiring HIV compared with infants born to women
previously diagnosed with HIV [3]. Transmission rates among
this group of infants are as high as 36% [4]. The World Health
Organization (WHO) recommends a four-pronged strategy to
prevent HIV vertical transmission, which includes the preven-
tion of HIV infection among women of reproductive age [5]. In
Africa, detection of HIV infection in women in late pregnancy
or in the postpartum period is uncommon as testing practices
often focus on testing at first antenatal visit.
Data on socio-demographic and behavioural risk factors
associatedwith acute HIV infection during pregnancy and post-
partum period are limited. In Kenya, the region and employ-
ment of the participant were independent risk factors [6]. A
study in Zimbabwe looking at socio-demographic and beha-
vioural risk factors showed time of seroconversion, level of
education of the participant and age as important factors [7].
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Mozambique has little data on acute HIV infection and
associated transmission risk factors, or on HIV incidence
among pregnant and breastfeeding women. The country has
a population of 22 million inhabitants, of which an estimated
25% are women of reproductive age. Southern Mozambique
is highly affected by the HIV epidemic with a prevalence of
20% in women aged 1549 years [8] and 21% in pregnant
women [9]. Mozambique’s Ministry of Health (MOH) estab-
lished a national program for prevention of mother-to-child
transmission (PMTCT) in 2002. By the end of 2010, 86% of
health facilities with antenatal care (ANC) provided PMTCT
services free-of-charge [10]. At the time of the study, the
program focused on ‘‘opt-out’’ HIV testing offered to all
pregnant women at the first ANC visit, repeat HIV testing at
delivery, and testing women of unknown status at any
Mother-and-Child Health (MCH) entry point postpartum.
Partner testing is available and encouraged, though uptake
remains low.
The 2011 Mozambique national vertical transmission rate
among infants less than or equal to twomonths was 7.4% with
an 18-month transmission rate of 19% [10]. The additional
infant infections reflect both on-going transmissions through
breastfeeding in known HIV-positive women as well as in
women with incident HIV infection during this period.
With the emphasis on preventing transmission to infants
born to HIV-positive women, primary prevention for women
identified as HIV-negative early in pregnancy is often neglec-
ted. This is a missed opportunity to reduce the incidence of
HIV in women aged 1549 by 50% and to meet the target of
the Global Plan for the elimination of paediatric HIV [11].
The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF)
has supported the national PMTCT program in Mozambique
since 2004. A prospective study was conducted to estimate
HIV incidence and associated risk factors among HIV-negative
postpartum women in Southern Mozambique.
Methods
Study design
A prospective cohort study was conducted between March
2008 and July 2011 in six rural primary health care facilities in
Gaza and Maputo provinces. Health facilities were selected
by convenience sampling, based on the high HIV prevalence
and a high attendance in MCH units. Study staff recruited
HIV-negative women attending MCH services in maternity
wards, postpartum care and family planning clinics. Enrolled
women were followed quarterly until 18 months postpartum.
Study population and procedures
Women aged ]18 years who delivered in a study health
facility or attended a postnatal visit within two months of
delivery, and tested HIV-negative at that time, were invited
to participate. HIV screening was performed per national
guidelines with the Determine HIV-1/2† (Abbott Labora-
tories, Wiesbaden, Germany) assay. The informed consent
process was conducted in Portuguese or Changana (the local
language), depending on the participants’ preference. Only
participants who provided written consent were enrolled in
the study.
At enrolment, participants responded to a questionnaire
administered by a trained study counsellor. The questionnaire
included socio-demographic information and questions re-
garding their sexual activity, condom use, occurrences of STIs,
information about their husband/partner, and knowledge
of HIV and PMTCT. A clinical examination was performed by
an MCH nurse.
Study follow-up visits were scheduled at 3, 6, 9, 12, 15 and
18 months postpartum. At each visit, the study counsellor
administered a questionnaire, women were counselled on
HIV prevention and testing, and a nurse performed a clinical
examination and HIV rapid antibody testing. Whole dried
blood spot (DBS) samples were collected and stored for later
confirmatory testing for all women with newly identified HIV
infection.
HIV-negative women were counselled and reminded of
their next study visit. Women who recently tested positive
to HIV received counselling on their result, were referred
for further HIV care and treatment and follow-up of their
HIV-exposed infant, and were then discharged from the
study. Results of the initial HIV DNA-PCR testing of infants of
newly diagnosed women, when available, were extracted
from routine PMTCT program records.
HIV DNA-PCR analysis (Roche Amplicor HIV-1 DNA Test,
version 1.5, Roche Molecular Diagnostics, Branchburg NJ,
USA) was performed on all DBS samples from women who
seroconverted to confirm HIV infection and to estimate the
time of infection. At HIV diagnosis, blood was taken for CD4-
cell count (FACSCount or FACSCalibur, both from Becton
Dickinson, San Jose, CA, USA) and HIV RNA viral load testing
(Cobas AmpliPrep/Cobas TaqMan HIV-1 test, version 2.0,
Roche Molecular Systems, Inc.). All DBS storage, and HIV DNA
and RNA testing was done at Instituto Nacional de Sau´de,
Maputo.
Several strategies were implemented to retain women:
1) participants were reimbursed for transport; 2) study
counsellors collected contact details with permission of the
participant and traced those who did not show up for one
month after the scheduled visit; and 3) the study ID was
written on the child health card for participant identification
at vaccination clinics and referral to the study counsellor.
Reasons for lost to follow-up (LFU) were explored using the
tracing registers.
Ethics
The protocol was approved by Mozambique’s National
Health Bioethics Committee. Written informed consent was
obtained from all participants.
Data collection and statistical analysis
Collected variables included clinical (e.g. sexually trans-
mitted infection), laboratory (e.g. HIV test results), socio-
demographic (e.g. age, marital status, educational level),
knowledge of HIV/PMTCT and sexual risk behaviour. Double
data entry was done using EpiData Version 1.1. Statistical
analyses were generated using SAS/STAT software, Version
9.2 of the SAS System for Windows (SAS Institute Inc., Cary,
NC, USA).
Seroincidence rates were calculated using the number of
new HIV infections per 100 women-years at risk, based on
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women’s exposure time. For non-seroconverters, the expo-
sure time was defined as the interval between enrolment and
the last HIV test. For seroconverters, the exposure time was
calculated as the interval between enrolment and estimated
time of HIV infection, defined as the midpoint between the
last negative test result and the first positive HIV test result.
Seroincidence rates were compared with women’s baseline
socio-demographic characteristics, knowledge on HIV/PMTCT
and sexual behaviours employing bivariable Poisson regres-
sion models using one exposure with one response. The HIV
vertical transmission rate among newly diagnosed women was
calculated as the proportion of HIV-infected infants over the
total number of infants with an initial HIV test after detection
of maternal seroconversion. Using the regional annual birth
rates, vertical transmission rates for women within and out
of the PMTCT program and our results on incidence and
vertical transmission rate, the contribution of postpartum HIV
incidence to vertical transmission was estimated.
Results
A total of 1221 women were enrolled in the study. Eleven
women were enrolled outside of the inclusion period, with a
median time of enrolment of 63 days (Interquartile Range
(IQR) 6189) postpartum, compared to a median of one
day (IQR 14) of enrolment of the others. After enrolment,
957 (78%) women had at least one follow-up visit and
were included in the analysis (Figure 1). The median follow-
up period for women in the analyzed cohort was 18.2
months (IQR 15.319.2) with a total follow-up time of 1278
women-years.
Despite the tracing mechanism that was put in place, only
664 (54%) women had a last follow-up visit at 18 months.
The average LFU rate per visit in the analyzed cohort was
8.8%. Main reasons for loss to follow-up included: incorrect
address, traveling, change in address and refusal by partici-
pant or family member.
Baseline characteristics
Table 1 shows the basic characteristics of the whole cohort
with disaggregated comparison of women with and without
any follow-up visits after enrolment visit.
The median age of participants at enrolment was 24 years
(IQR 2029). Seventy percent of the women (851/1221) were
married or lived permanently with their partner. Average
education level among women was low: 66% (799/1221) had
no education or did not finish primary education. The median
age of first childbearing was 19 years (IQR 1720). At 12-
and 18-month follow-up visits, 16/639 (2.5%) and 246/661
(37%) respondents, respectively, said they had stopped
breastfeeding.
Women with no follow-up visits after enrolment differed
significantly from women in the analyzed cohort in pro-
vince, partners’ level of education and type of employment.
Participants retained in the cohort to the end of follow-
up differed in the same variables (pB0.0001, p0.01 and
pB0.0001 respectively) from those lost during the follow-up
period (data not shown).
HIV incidence
During the follow-up period, 41 incident HIV infections
were identified among the 957 women with at least one
Figure 1. Flow of participants during the study. SC, seroconversion; LFU, lost to follow-up; pp; postpartum; neg, negative.
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Table 1. Baseline characteristics of all participants included in the study (n1221), by the presence of any follow-up visit
Total No follow-up visit (N) Follow-up visit (N) Chi-square test (p-value)
Number (total) 1221 264 957 
Province    B0.0001
Maputo 600 101 (38%) 499 (52%) 
Gaza 621 163 (62%) 458 (48%) 
Age (years)    
Mean (9sd) 25 (1931) 25 (1832) 25 (1931) 
Median (IQR) 24 (2029) 24 (2029) 24 (2029) 
Missing 23 13 10 
Age category (years)    0.2
1819 213 49 (19%) 164 (17%) 
2024 420 79 (30%) 341 (36%) 
2529 280 62 (23%) 218 (23%) 
3034 167 29 (11%) 138 (14%) 
34 118 32 (12%) 86 (9%) 
Missing 23 13 (5%) 10 (1%) 
Parity    0.4
B3 566 111 (42%) 455 (48%) 
]3 628 135 (51%) 493 (51%) 
Missing 27 18 (7%) 9 (1%) 
Age at first child    
Mean (9sd) 18 (1620) 18 (1323) 19 (1721) 
Median (IQR) 19 (1720) 18 (1719) 18 (1720) 
Missing 227 64 163 
Marital status    0.2
Married/living with partner 851 186 (70%) 665 (70%) 
Divorced/separated/widow/single 241 41 (16%) 200 (21%) 
In relationship but not living with partner 118 28 (11%) 90 (9%) 
Missing 11 9 (3%) 2 (0%) 
Polygamy    0.2
No polygamous marriage 657 147 (56%) 510 (53%) 
Polygamous marriage 119 33 (12%) 86 (9%) 
Missing 445 84 (32%) 361 (38%) 
Educational level    0.2
Less than primary education 799 182 (69%) 617 (64%) 
Primary education or higher 422 82 (31%) 340 (36%) 
Partner educational level    0.01
Less than primary education 536 129 (49%) 407 (43%) 
Primary education or higher 495 88 (33%) 407 (43%) 
Missing 190 47 (18%) 143 (15%) 
History of professional life    0.5
Never had a job 1016 210 (80%) 806 (84%) 
Ever had a job 184 42 (16%) 142 (15%) 
Missing 21 12 (4%) 9 (1%) 
Partner employment    B0.0001
Unemployed 211 44 (17%) 167 (717) 
Own business 184 35 (13%) 149 (16%) 
Employee 247 40 (15%) 207 (22%) 
Mineworker 330 106 (40%) 224 (24%) 
Others 116 15 (6%) 101 (10%) 
Missing 133 24 (9%) 109 (11%) 
Boldfaces means significant (pB0.05).
De Schacht C et al. Journal of the International AIDS Society 2014, 17:18808
http://www.jiasociety.org/index.php/jias/article/view/18808 | http://dx.doi.org/10.7448/IAS.17.1.18808
4
follow-up visit. HIV diagnosis was confirmed by DNA-PCR in
all but one case due to lack of a biological specimen.
The overall incidence among women during postpartum
period was 3.20 per 100 woman-years (95% CI: 2.304.46).
The highest incidence of 4.92 (95% CI: 2.659.15) was seen
in the youngest age group of 1819 years, with decreasing
incidence with older age. Incidence was 3.39 (95% CI: 2.08
5.53) between 20 and 24 years; 3.49 (95% CI: 1.886.49)
between 25 and 29 years; 2.16 (95% CI: 0.815.76) be-
tween 30 and 34 years and 0.84 (95% CI: 0.125.93) above
34 years. The median age at study enrolment of women who
seroconverted was 22 (IQR 2025) years.
Of all seroconversions, 14 (34%) were identified during
the first six months postpartum, 11 (27%) between 6 and 12
months and 16 (39%) occurred in the period 1218 months
postpartum. The median time from enrolment to time of
serological diagnosis of HIV was 299 days (IQR 183489).
The incidence was slightly but not significantly higher in
Gaza Province (3.62; 95% CI: 2.365.55) than in Maputo
Province (2.86; 95% CI: 1.844.43).
Participants with HIV seroconversion were referred for
further clinical care and staging, CD4-cell counting and anti-
retroviral treatment (ART), if eligible. The median CD4-cell
count among 24 seroconverters tested was 604 cells/ml (IQR
429820) and the median viral load was 22,378 copies/ml
(IQR 8,131113,497) (n26). Six participants refused blood
collection for CD4-cell count at the time of seroconversion
and one result was lost. Results of 10 participants were not
available to the study staff due to referral of participants
from a study site to another health facility.
Risk factors for seroconversion
Incidence was significantly higher in women whose partners
had a higher educational level (p0.01) and among women
with fewer children (p0.03) (Table 2). Being in a relation-
ship but not living with the biological father doubled the
risk for HIV infection, compared to being married or living
together. Younger women were more at risk: for every one-
year increase in age, incidence decreased 0.93 per woman-
year (95% CI: 0.870.99; Table 2).
Ninety eight percent of the respondents had heard of HIV
and AIDS (Table 3) and 99% of the participants had heard
about vertical HIV transmission. When asked how women
transmit infection to babies, 28% of women mentioned all
three modes of vertical transmission. Those who did not
identify transmission via breast milk had about a two-fold
increased risk of infection (p0.06; Table 3).
Among sexual/behavioural risk factors collected at the
time of enrolment, only having sex with a partner outside of
their relationship increased HIV risk significantly (p0.001,
Table 4). Women with sexual debut before 17 years of age
were at almost twice-higher risk (p0.13) but this was not
statistically significant.
Infant outcomes
Data on the initial HIV testing of infants of women who sero-
converted were available in routine records for 29 infants. One
child died before maternal seroconversion was detected; the
remaining 11 motherinfant pairs were LFU before an infant
DBS samplewas collected.Themedian time from identification
ofmaternal seroconversion to infantDBS samplingwas 52 days
(IQR 099). Thirteen infants were tested the same day as the
maternal HIV diagnosis. The median age of infants at the time
of HIV testing was 12.6 months (IQR 8.917.0). Six of the
29 tested infants were HIV-positive (21%; 95% CI: 536).
Five HIV positive infants were tested on the same day as the
maternal HIV diagnosis and one was tested two months
after maternal diagnosis. All HIV-infected infants were referred
for ART initiation according to the national guidelines. No
further infant follow-up information was available.
Maternal CD4-cell count was associated with infant infec-
tion at first infant HIV test: among 16 women with a CD4-
cell count350 cells/ml and known infant infection status,
two had HIV-infected infants, while both infants from the
two mothers with a CD4-cell count 5350 cells/ml were
HIV-infected (Fisher’s Exact test, p0.006). No significant
association was seen between maternal viral load and infant
HIV status: none of the six infants of mothers with a viral load
510,000 copies/ml and six infants of 23 mothers with a viral
load10,000 copies/ml were HIV infected (Fisher’s Exact
test, p0.168).
Estimation of the effect of postpartum HIV incidence
on HIV infections in children
With the postpartum HIV incidence of 3.20 per 100 women-
years and a 21% vertical transmission rate in this study, we
estimated the proportion of HIV-infected children attributa-
ble to postpartum seroconversion. With an annual estimated
number of births of 93,718 in Gaza and Maputo provinces
[12] and a HIV prevalence in pregnancy of 21% [9], 19,681
mothers will be HIV-positive at time of delivery. For those
who have access to health facilities (58% of pregnant women
[13]) and the estimated postpartum vertical transmission rate
within the PMTCT program of 12% [10], 1,370 infants are
estimated to be HIV-infected. Women without access to
services have an increased risk of transmission of 31% [14],
resulting in 2,562 HIV-infected infants. With 3.2 incident
infections per 100 women-years, 3,554 of the 74,037 HIV-
negative mothers at delivery will be infected during the first
18 months postpartum. With a postpartum vertical transmis-
sion rate of 21%, 746 infants are estimated to become
infected  thus, 16% (746/4,678) of the HIV-infected infants
are due to a postpartum incident infection in women (see
Supplementary file).
Discussion
Our study shows a high HIV incidence (3.20 per 100 women-
years) in women during the postpartum period in a high
prevalence region of Mozambique, with the subsequent
transmission to infants accounting for one in six HIV-infected
infants. This first description of HIV incidence in this popu-
lation is consistent with studies in similar populations in
other sub-Saharan African countries [1419]. Our study con-
firms an active epidemic in the Southern region of the
country, which was suggested in the epidemic trend analysis
conducted in 2009 [9] using the Estimation and Projection
Package [20].
The high incidence among postpartum women aged 1819
years (4.92 per 100 women-years), is consistent with results
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from Zimbabwe [21] and non-pregnant young women (524
years) in Kwazulu-Natal [22]. However, in a recent study
among 1824 year olds with higher education levels in
Maputo City, an overall incidence of 1.14 per 100 person-
years (95% CI: 0.882.51), and 1.49 per 100 person-years
(95% CI: 0.671.92) in female youth was observed (Viegas,
personal communication, 2013). Factors associated with this
considerable difference, such as pregnancy, rural or urban
setting, education, or other social factors should be further
explored. As young people are at a high risk of HIV infection,
sexual education and integrated HIV education and preven-
tion programs in the primary and secondary schools are
important in the efforts to reduce risk behaviour.
Although a small number of infants were tested, a vertical
transmission rate among seroconverters of 21% was seen,
similar to findings from other studies with estimated rates
higher than 20% [3,14]. However, this needs to be inter-
preted with caution given the small numbers, wide CI and
Table 2. Comparison of HIV incidence rates for demographic risk factors using bivariable Poisson regression models (n957)
Number Number SC Risk ratio (95% CI) p-value*
Province    
Maputo 499 20  
Gaza 458 21 1.27 (0.692.34) 0.45
Age (years) 947 41 0.93 (0.870.99) 0.02
Age category (years)    
1819 164 10  
2024 341 16 0.67 (0.311.52) 0.36
2529 218 10 0.71 (0.301.71) 0.44
3034 138 4 0.44 (0.141.40) 0.16
34 86 1 0.17 (0.021.33) 0.09
Marital status    
Married or living together 665 24  
Divorced/separated/widow/single 200 10 1.37 (0.662.87) 0.40
Relationship but not living with partner 90 7 2.13 (0.924.95) 0.08
Polygamous marriage    
No 508 17  
Yes 86 5 1.75 (0.644.73) 0.27
Number of children    
B3 455 26  
]3 493 14 0.48 (0.250.93) 0.03
Educational level    
Less than primary education 617 26  
Primary education or higher 340 15 0.99 (0.521.86) 0.96
Partner educational level    
Less than primary education 407 10  
Primary education or higher 407 22 2.10 (1.014.50) 0.05
Ever had a job    
No 806 34  
Yes 142 7 1.14 (0.502.57) 0.76
Partner employment    
No job 167 6  
Employee 208 3 1.71 (0.614.80) 0.31
Mineworker 225 8 0.38 (0.091.51) 0.17
Other 101 5 1.02 (0.352.93) 0.98
Own business 149 9 1.23 (0.364.03) 0.73
Partner works out 4 weeks    
No 604 28  
Yes 324 10 0.67 (0.321.38) 0.27
SC, seroconversion; CI, confidence interval.
*p-values from Poisson regression models (i.e. generalized linear models using the Poisson distribution with the log link and an offset accounting
for person-years).
Boldfaces means significant (pB0.05).
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missing infant HIV status results for 12 infants. The vertical
transmission rate would range from 15% to 44% if none
or all of these 12 infants were considered HIV-infected,
respectively. The long breast feeding period and consider-
able number of women who were still breastfeeding at
18 months indicates continued risk of additional infant
transmission.
Early identification of incident infection in postpartum
women and immediate testing of their children is critical for
initiating ARV prophylaxis to prevent infection in infants
found to be uninfected and initiating ART for HIV-infected
infants. While HIV disease progression in postnatally infected
infants has been associated with slower disease progression
than perinatally infected infants [23], current WHO guidelines
recommend ART for all children under five [24].
At the time of the study, Mozambique followed the 2006
WHO PMTCT guidelines that did not include postpartum
antiretroviral prophylaxis. With the recent implementation of
PMTCT Option B, offering lifelong ART to all HIV-positive
pregnant and lactating women [25], it is expected that the
overall risk of vertical transmission will decrease significantly.
Routine regular repeat HIV testing for negative postpartum
women will be required to realize the benefits of Option B
for women with acute HIV infection, especially since 66% of
the seroconversions occurred after six months postpartum.
Given the time that it takes for ART to decrease viral load,
immediate nevirapine prophylaxis in infants may decrease
the transmission risk further.
Repeat testing strategies will not be sufficient to reduce
the number of infant infections due to maternal postnatal
incidence as infant infection is likely to occur before the
diagnosis of infection in the mother and retention of HIV-
negative women in postpartum care is a challenge. Therefore
focused attention on comprehensive primary prevention for
all HIV-negative women in antenatal and MCH settings is
critical, and often lacking. This includes HIV testing of partners
of HIV-negative women, which is critical for identification
of discordant couples and intervention with ART for the part-
ner or pre-exposure prophylaxis for the woman to decrease
the chance of transmission [24,26]. Associations between
partner characteristics and HIV incidence in postpartum
women emphasize the need to involve both partners in
primary prevention efforts.
There is clear benefit of early ART on prevention of
HIV infection [27,28]. Expansion of ART programs through-
out Mozambique and other African countries should also
Table 3. Comparison of HIV incidence rates for baseline knowledge-based risk factors using bivariable Poisson regression models
(n957)
Number Number SC Risk ratio (95% CI) p-value*
Ever heard of AIDS?    
No 22 2  
Yes 929 38 0.43 (0.101.77) 0.24
Ever heard of vertical transmission?    
No 10 1  
Yes 930 40 0.47 (0.063.40) 0.45
Identification of risk of vertical transmission through pregnancy    
No 387 20  
Yes 479 18 0.70 (0.371.32) 0.27
Identification of risk of vertical transmission through delivery    
No 462 20  
Yes 404 18 1.03 (0.541.94) 0.93
Identification of risk of vertical transmission through breastfeeding    
No 100 8  
Yes 766 30 0.47 (0.221.03) 0.06
Is there treatment for HIV?    
No 7 0 0 (0) 0.999
Yes 896 37  
Is there cure for HIV?    
No 666 28  
Yes 197 6 1.43 (0.643.32) 0.39
Can transmission be decreased by condom use?    
No 16 0 0 (0) 0.999
Yes 903 37  
SC, seroconversion; CI, confidence interval.
*p-values from Poisson regression models (i.e. generalized linear models using the Poisson distribution with the log link and an offset accounting
for person-years).
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contribute to a reduced incidence of HIV in postpartum
women and subsequently in their infants. Mozambique’s
HIV policy provides universal access to ART for HIV-positive
partners of HIV-negative pregnant women, which should
contribute to a decrease in incidence.
However, partner testing remains low. The Southern pro-
vinces of the country are known for their migrant population,
with a great number of men working abroad. In our study,
27% of women had partners who were mineworkers in
South Africa. Moreover, the Southern region has a cultural
paternal tradition that hinders male involvement in repro-
ductive health.
Counselling and testing points at bus stops of migrant
workers, working with the companies to provide employee
testing, testing campaigns during the holiday season in
the community or at gathering places are strategies to be
evaluated to increase both partner testing and periodic re-
testing of postpartum women.
Table 4. Comparison of HIV incidence rates for sexual/ behavioural-type risk factors using bivariable Poisson regression models
(n957)
Number Number SC Risk ratio (95% CI) p-value*
Age at first sexual activity (years) 713 31 0.84 (0.691.03) 0.09
Age at first sexual activity (years)    
516 377 20  
16 336 11 0.57 (0.271.19) 0.13
Self risk assessment    
No risk 42 1  
Medium risk 351 15 1.88 (0.2414.23) 0.54
High risk 59 9 1.91 (0.2415.12) 0.54
Ever tested for HIV?    
No 93 4  
Yes 837 34 0.94 (0.332.65) 0.91
Knowledge if partner was ever tested for HIV    
Was not tested 546 21  
Was tested 232 8 0.85 (0.381.92) 0.70
Don’t know if was tested 151 10 1.74 (0.823.70) 0.15
Condom use with partner    
Never 757 28  
Sometimes 172 11 1.73 (0.863.47) 0.12
Always 5 0 0 (0) 0.999
Ever had sex with other person than partner?    
No 922 39  
Yes 4 2 16.91 (3.9167.05) B0.001
Knowledge if partner had ever sex with others    
No 297 13  
Yes 133 7 1.13 (0.452.84) 0.79
Ever used something to dry vagina?    
No 685 29  
Yes 232 11 1.08 (0.542.15) 0.84
Ever experienced domestic violence by partner?    
No 863 38  
Yes 87 3 0.80 (0.252.59) 0.71
Ever experienced sexual violence by partner?    
No 919 40  
Yes 29 1 0.68 (0.094.98) 0.71
Treated for STD at first visit    
No 759 34  
Yes 12 0 0 (0) 0.9997
SC, seroconversion; CI, confidence interval.
*p-values from Poisson regression models (i.e. generalized linear models using the Poisson distribution with the log link and an offset accounting
for person-years).
The values in bold are the ones that are significant (pB0.05).
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Our research had several limitations: the differential high
loss to follow-up over time could lead to biased incidence
estimates, such as an overestimation due to higher retention
of women with partners with a higher education, which is
associated with an increased risk of incident infections.
Multivariate Poisson regression analyses were not possible
to perform with sufficient power due to the low number
of incident HIV infections. Similarly, there was insufficient
power to conduct a longitudinal analysis comparing knowl-
edge, sexual/behavioural risk factors over time due to low or
irregular follow-up. With the small number of infants tested,
transmission rates need to be interpreted with caution.
There is also a risk of reporting bias, as women report on
their and their partners’ behaviour. Finally, we cannot extra-
polate the results to other regions in Mozambique due
to different epidemic profiles and socio-culturally different
populations.
Conclusions
The high incidence of HIV in postpartum women in Southern
Mozambique and similar African populations underscores
the importance of effective primary prevention strategies
targeting breastfeeding women and their partners in the
elimination of paediatric HIV efforts. Achieving the ‘‘Global
Plan’’ targets [11] will require a comprehensive combination
prevention strategy with community, behavioural and bio-
medical interventions, such as pre-exposure prophylaxis
during breastfeeding, adapted to these vulnerable popula-
tions in high prevalence settings. Tracking HIV incidence over
time will be critical for monitoring the effects of current
prevention and expanding ART programs.
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